SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001130319-08-000358
Filing Date
2008-05-01
Accepted
2008-05-01 15:25:43
Documents
3
Period of Report
2008-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K o40369e6vk.htm 6-K 175260
2 GRAPHIC o40369o4036900.gif GRAPHIC 4267
3 GRAPHIC o40369o4036901.gif GRAPHIC 1444
  Complete submission text file 0001130319-08-000358.txt   184857
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 08794397
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1